The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
As investors move to re-evaluate high-multiple growth stocks, Ecolab (ECL) is facing notable selling pressure. According to reports, the stock has declined by 8.3% over the past three months despite maintaining a positive long-term earnings trajectory. Analysts highlight that the current P/E ratio of 34.5x stands significantly above industry averages and estimated fair value metrics, raising concerns about the stock's immediate upside potential.
Compared to peers in the specialty chemicals sector, ECL trades at a distinct premium; the global chemicals sector average P/E ratio sits near 18.4x per market data from Refinitiv. While search data shows the company delivered 5% organic sales growth in its last quarterly report, this performance is being weighed against a valuation that exceeds competitors like Sherwin-Williams, which trades at approximately 29x earnings per search citations.
Sign in to access this content
Sign InECL shares closed at $256.99 (close June 10, 2026), after touching a session low of $255.09 and a high of $265.16 per pre-fetched data. Traders are currently monitoring support levels near the $255 mark, and with no major corporate catalysts in the upcoming economic calendar, the stock's direction will likely depend on broader materials sector flows and global consumer confidence trends.